Duraplasty Graft Seals Cerebrospinal Fluid Leaks
|
By HospiMedica International staff writers Posted on 17 Mar 2014 |

Image: The Biodesign Duraplasty Graft in situ (Photo courtesy of Cook Medical).
A new treatment option is now available for the repair the dura mater following cerebrospinal fluid (CSF) leaks at the base of the skull.
The Biodesign Duraplasty Graft is a non-dermis, non-cross-linked biologic graft that is designed for repairs of the dura mater, the thick membrane that is the outermost of the three layers of the meninges that surround the brain and spinal cord, and is responsible for keeping in the CSF; it is derived from mesoderm. The Biodesign graft itself is derived from a natural material that is easy to manipulate, does not swell with hydration, and does not fold onto itself. Once in place, the body completely remodels the graft into strong, well-vascularized tissue.
The graft can be placed with or without sutures and it can achieve a strong seal, so that it provides a well-balanced treatment option. It can also be used to treat existing CSF leaks, such as those resulting from trauma or sinus surgery at the skull base. Another benefit of Biodesign graft is that it reduces the need to harvest tissue from other parts of the body for use in the repair. The Biodesign Duraplasty Graft is a product of Cook Medical (Bloomington, IN, USA), and has been approved by the US Food and Drug Administration (FDA).
“Biodesign’s proven tissue repair technology works in different grafting procedures,” said Thomas Cherry, RN, OHNS global leader of the Cook Medical Otolaryngology – Head and Neck Surgery (OHNS) clinical division. “We’re excited to introduce the device to otolaryngologists and expand OHNS’s Biodesign line. Because of Biodesign’s excellent handling characteristics, physicians can secure the Biodesign graft during skull-base dura mater reconstruction with or without suturing.”
“I started using Biodesign because I found it easier to handle during the endoscopic repair than competing products,” said Bradford Woodworth, MD, director of otolaryngology research at the University of Alabama (Birmingham, USA). “Although not directly measured, I feel it contributes to faster graft placement and increased operative speed.”
Related Links:
Cook Medical
University of Alabama
The Biodesign Duraplasty Graft is a non-dermis, non-cross-linked biologic graft that is designed for repairs of the dura mater, the thick membrane that is the outermost of the three layers of the meninges that surround the brain and spinal cord, and is responsible for keeping in the CSF; it is derived from mesoderm. The Biodesign graft itself is derived from a natural material that is easy to manipulate, does not swell with hydration, and does not fold onto itself. Once in place, the body completely remodels the graft into strong, well-vascularized tissue.
The graft can be placed with or without sutures and it can achieve a strong seal, so that it provides a well-balanced treatment option. It can also be used to treat existing CSF leaks, such as those resulting from trauma or sinus surgery at the skull base. Another benefit of Biodesign graft is that it reduces the need to harvest tissue from other parts of the body for use in the repair. The Biodesign Duraplasty Graft is a product of Cook Medical (Bloomington, IN, USA), and has been approved by the US Food and Drug Administration (FDA).
“Biodesign’s proven tissue repair technology works in different grafting procedures,” said Thomas Cherry, RN, OHNS global leader of the Cook Medical Otolaryngology – Head and Neck Surgery (OHNS) clinical division. “We’re excited to introduce the device to otolaryngologists and expand OHNS’s Biodesign line. Because of Biodesign’s excellent handling characteristics, physicians can secure the Biodesign graft during skull-base dura mater reconstruction with or without suturing.”
“I started using Biodesign because I found it easier to handle during the endoscopic repair than competing products,” said Bradford Woodworth, MD, director of otolaryngology research at the University of Alabama (Birmingham, USA). “Although not directly measured, I feel it contributes to faster graft placement and increased operative speed.”
Related Links:
Cook Medical
University of Alabama
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







